Egyptian International Pharmaceutical Industries Co. (PHAR) Financials
Annual financial statement highlights for Egyptian International Pharmaceutical Industries Co. covering fiscal years 2006–2025. Figures are updated weekly.
| Fiscal year | Revenue | Net income | EPS | Free cash flow | Total assets | Total debt | Dividend per share |
|---|---|---|---|---|---|---|---|
| 2025ended Dec 2025 | 9.44B | 1.44B | 8.90 | -109.98M | 18.27B | 8.81B | 3.50 |
| 2024ended Dec 2024 | 7.59B | 1.1B | 7.37 | -3.92B | 15.37B | 9.23B | 3.00 |
| 2023ended Dec 2023 | 5.23B | 822.32M | 5.53 | -2.16B | 9.98B | 4.92B | 2.00 |
| 2022ended Dec 2022 | 3.96B | 642.98M | 4.99 | -830.36M | 6.77B | 2.86B | 1.54 |
| 2021ended Dec 2021 | 3.41B | 487.75M | 3.78 | 9.61M | 5.23B | 1.76B | 2.31 |
| 2020ended Dec 2020 | 2.89B | 494.29M | 3.84 | 34.04M | 5.03B | 1.79B | 2.27 |
| 2019ended Dec 2019 | 3.41B | 679.29M | 5.20 | 208.34M | 4.41B | 1.02B | 3.13 |
| 2018ended Dec 2018 | 2.82B | 703.98M | 5.43 | -29.92M | 3.87B | 535.97M | 3.08 |
| 2017ended Dec 2017 | 2.53B | 688.36M | 5.34 | 211.95M | 3.35B | 136.61M | 2.77 |
| 2016ended Dec 2016 | 1.97B | 487.49M | 3.78 | 559.08M | 2.77B | 9.29M | 2.15 |
| 2015ended Dec 2015 | 1.7B | 371.22M | 2.88 | 311.31M | 2.53B | 220,000 | 2.15 |
| 2014ended Dec 2014 | 1.58B | 320.32M | 2.48 | 179.59M | 2.48B | 0 | 2.03 |
| 2013ended Dec 2013 | 1.36B | 312.59M | 2.42 | 138.77M | 2.37B | 0 | 1.85 |
| 2012ended Dec 2012 | 1.25B | 306.01M | 2.37 | 226.51M | 2.32B | 0 | 1.85 |
| 2011ended Dec 2011 | 1.16B | 317.16M | 2.46 | 273.51M | 2.25B | 0 | 1.85 |
| 2010ended Dec 2010 | 1.11B | 341.43M | 2.91 | 261.01M | 2.1B | 0 | 1.54 |
| 2009ended Dec 2009 | 1B | 298.1M | 2.31 | 214.72M | 1.85B | 0 | 0.62 |
| 2008ended Dec 2008 | 910.08M | 256.61M | 1.99 | 108.27M | 1.67B | 0 | 1.12 |
| 2007ended Dec 2007 | 850.23M | 231.93M | 1.80 | 147.5M | 1.61B | 0 | 1.01 |
| 2006ended Dec 2006 | 745.34M | 196.54M | 1.52 | 216.78M | 1.49B | 0 | 0.84 |
All figures in EGP, as reported in the company’s annual results; updated weekly.